COMMUNIQUÉS West-GlobeNewswire
-
Déclaration Intermédiaire Premier Trimestre 2026: un début d’année sur la bonne voie, avec des avancées en matière d’innovation produits
21/05/2026 -
Novartis advances RLT innovation and reinforces leadership in prostate cancer, breast cancer and hematology with new data at ASCO and EHA
21/05/2026 -
First quarter 2026 update: starting the year on track, with product innovation progress
21/05/2026 -
Relay Therapeutics Announces Pricing of Public Offering of Common Stock
21/05/2026 -
NeuroZen Under Investigation - Critical Assessment Reveals Shocking Consumer Report Details Disclosed
21/05/2026 -
Sifts Microplastic Binding Supplement Claims Evaluated: The Chitosan Fiber Formula for Daily Microplastic Particle Exposure Support
21/05/2026 -
Dyne Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
20/05/2026 -
BioAdaptives Launches MyndSystem™ Website — The First Supplement Platform Designed to Support Both Daytime Cognitive Performance and Overnight Brain Recovery
20/05/2026 -
LeMaitre to Participate at Upcoming Investor Conferences in June
20/05/2026 -
Informations sur le nombre total de droits de vote et d'actions
20/05/2026 -
Information on the total number of voting rights and shares
20/05/2026 -
CVRx to Present at the William Blair 46th Annual Growth Stock Conference
20/05/2026 -
L’Assemblée Générale Mixte de Cellectis se tiendra le le 25 juin 2026
20/05/2026 -
Nanobiotix annonce le lancement d’une offre globale
21/05/2026 -
Cellectis’ Annual Shareholders General Meeting to be Held on June 25, 2026
20/05/2026 -
Nanobiotix Announces Launch of Global Follow-On Offering
21/05/2026 -
Strongest Phentermine Alternatives 2026: What OTC Options Are Commonly Compared to Phentermine? PhenQ Formulation Assessment Using the SCALE-9 Evaluation Model
20/05/2026 -
Nanobiotix Announces Launch of Global Follow-On Offering
21/05/2026 -
Johns Hopkins Health Plans Awards $60,000 to Maryland and Virginia Organizations
20/05/2026
Pages